Cold & Cough Remedies (Pharmacies) - Uruguay

  • Uruguay
  • Revenue in the Cold & Cough Remedies market is projected to reach US$100.80m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 5.88%, resulting in a market volume of US$134.10m by 2029.
  • In global comparison, most revenue will be generated in China (US$7,826.00m in 2024).
  • In relation to total population figures, per person revenues of US$29.45 are generated in 2024.

Key regions: Canada, United Kingdom, United States, China, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Uruguay has been experiencing steady growth in recent years, driven by several key factors.

Customer preferences:
Uruguayan consumers have shown a growing preference for over-the-counter cold and cough remedies, as they seek immediate relief from symptoms without the need for a prescription. This trend is in line with global consumer behavior, as people increasingly take a proactive approach to managing their health and well-being. Additionally, the convenience of purchasing these remedies at pharmacies, which are easily accessible throughout the country, has further fueled customer demand.

Trends in the market:
One notable trend in the Cold & Cough Remedies (Pharmacies) market in Uruguay is the increasing demand for natural and herbal remedies. Consumers are becoming more health-conscious and are seeking products that are perceived as safer and more holistic. As a result, there has been a rise in the availability and sales of natural remedies such as herbal teas, honey-based cough syrups, and essential oil blends. This trend is also driven by a growing interest in traditional medicine and alternative therapies. Another trend in the market is the expansion of product offerings to cater to specific customer needs. Cold and cough remedies are now available in various formats such as tablets, syrups, lozenges, and nasal sprays, providing consumers with a wide range of options to choose from. Additionally, there has been a focus on developing products that target specific symptoms such as nasal congestion, sore throat, and cough, allowing consumers to find relief for their specific discomfort.

Local special circumstances:
Uruguay's relatively high healthcare expenditure and well-developed healthcare system have contributed to the growth of the Cold & Cough Remedies (Pharmacies) market. The country has a strong pharmaceutical industry and a large number of pharmacies, making it easy for consumers to access cold and cough remedies. Furthermore, the government's emphasis on healthcare and well-being has created a favorable environment for the growth of the market.

Underlying macroeconomic factors:
Uruguay's stable economy and increasing disposable incomes have also played a role in the development of the Cold & Cough Remedies (Pharmacies) market. As people have more money to spend on healthcare and wellness products, the demand for cold and cough remedies has risen. Additionally, the aging population in Uruguay has contributed to the growth of the market, as older individuals are more susceptible to cold and cough symptoms and are more likely to seek remedies to alleviate their discomfort. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Uruguay is experiencing growth due to customer preferences for over-the-counter remedies, the increasing demand for natural and herbal products, the expansion of product offerings, the country's well-developed healthcare system, and favorable macroeconomic factors. As these trends continue, the market is expected to further expand in the coming years.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)